Royce & Associates LP Heron Therapeutics, Inc. Transaction History

Royce & Associates LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$10.89 - $21.47 $790,614 - $1.56 Million	-72,600 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$17.42 - $26.61 $45,292 - $69,186	2,600 Added 3.71%	72,600 $1.71 Million
Q4 2018 Feb 11, 2019	BUY	$22.03 - $32.01 $110,150 - $160,050	5,000 Added 7.69%	70,000 $1.82 Million
Q2 2018 Aug 09, 2018	SELL	$26.4 - $42.0 $462,000 - $735,000	-17,500 Reduced 21.21%	65,000 $2.53 Million
Q4 2017 Feb 09, 2018	BUY	$14.8 - $18.85 $222,000 - $282,750	15,000 Added 22.22%	82,500 $1.49 Million
Q3 2017 Nov 13, 2017	BUY	$14.65 - $16.85 $146,500 - $168,500	10,000 Added 17.39%	67,500 $1.09 Million
Q2 2017 Aug 07, 2017	BUY	N/A	57,500	57,500 $796,000

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.